Although DPA-derived metabolites, named protectin D1n−3 DPA (PD1n−3 DPA) and resolvin D5n−3 DPA (RvD5n−3 DPA), have been found to suppress chronic inflammation [19,122] and their role in cancer, and CRC has not been elucidated yet. Here, CD59 is linked to colorectal carcinoma.